4.5 Article

Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress:: role of ferrous and ferric ions

Journal

NEUROCHEMISTRY INTERNATIONAL
Volume 45, Issue 1, Pages 103-116

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuint.2003.11.018

Keywords

dopamine autoxidation; dopamine metabolism; hydroxyl radical; lipid peroxidation; protein oxidation; mitochondrial preparations; Parkinson's disease

Ask authors/readers for more resources

The autoxidation and monoamine oxidase (MAO)-mediated metabolism of dopamine (3-hydroxytyramine; DA) cause a continuous production of hydroxyl radical ((OH)-O-.), which is further enhanced by the presence of iron (ferrous iron, Fe2+ and ferric ion, Fe3+). The accumulation of hydrogen peroxide (H2O2) in the presence of Fe2+ appears to discard the involvement of the Fenton reaction in this process. It has been found that the presence of DA significantly reduces the formation of thiobarbituric acid reagent substances (TBARS), which under physiological conditions takes place in mitochondrial preparations. The presence of DA is also able to reduce TBARS formation in mitochondrial preparations even in the presence of iron (Fe2+ and Fe3+). However, DA boosted the carbonyl content of mitochondrial proteins, which was further increased in the presence of iron (Fe2+ and Fe3+). This latter effect is also accompanied by a significant reduction in thiol content of mitochondrial proteins. It has also been observed how the pre-incubation of mitochondria with pargyline, an acetylenic MAO inhibitor, reduces the production of (OH)-O-. and increases the formation of TBARS. Although, the MAO-mediated metabolism of DA increases MAO-B activity, the presence of iron inhibits both MAO-A and MAO-B activities. Consequently, DA has been shown to be a double-edged sword, because it displays antioxidant properties in relation to both the Fenton reaction and lipid peroxidation and exhibits pro-oxidant properties by causing both generation (OH)-O-. and oxidation of mitochondrial proteins. Evidently, these pro-oxidant properties of DA help explain the long-term side effects derived from L-DOPA treatment of Parkinson's disease and its exacerbation by the concomitant use of DA metabolism inhibitors. (C) 2003 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available